You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
Cells die in many ways. Apoptosis is an immunologically silent cell death program that is important for embryonic development. By contrast, pyroptosis is a proinflammatory mode of cell death that is triggered by diverse infectious and sterile insults. Many cell types are pyroptosis-competent, including hematopoietic, epithelial, and endothelial cells. Inhibiting pyroptosis ameliorates disease, including septic shock and autoinflammation, in multiple preclinical mouse models. Thus, attenuating aberrant or excessive pyroptosis may be clinically beneficial, despite a role of pyroptosis in pathogen defense. Pyroptosis is driven by the pore-forming fragment of the gasdermin D (GSDMD) protein, which is proteolytically generated by the cysteine protease caspases 1, 4, 5, and 11 in response to activation of the inflammasome (a multiprotein complex that detects infectious and sterile insults). Recent clinical findings emphasize the critical role of pyroptosis in human inflammatory disease and cancer, and this has galvanized focus on GSDMD as a therapeutic target.
This is an article distributed under the terms of the Science Journals Default License.